Elevated IL-6 levels were also reported in LSDs, including patients with Gaucher disease (associated with the expansion of myeloid cells) (28) and those MPS IVA patients undergoing ERT (combined with induced pro-oxidant states) (42). This evidence concerns the gene IL6 and Gaucher disease.